National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Health Research Institutes - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9310
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Health Research Institutes (NHRI) is a non-profit foundation that performs medical research programs. The foundation investigates various aspects of basic biomedical sciences and diseases including aging, cancer, infectious diseases, mental disorders and occupational diseases. It conducts research programs in the areas of cancer, cellular and systems medicine, aging related musculoskeletal diseases, population health sciences, regenerative medicine, molecular and genomic medicine, infectious diseases and vaccinology, medical engineering, and others. NHRI plans the overall direction of national science and technology development in health and medical care. The foundation also coordinates, integrates, and supports research activities undertaken by medical institutions. It operates with an additional office in Taipei. NHRI is headquartered in Zhunan, Taiwan.

National Health Research Institutes – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Health Research Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
National Health Research Institutes, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Molecular Targeting Enters into Co-Development Agreement with National Health Research Institutes 10
Licensing Agreements 11
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
Medigen Vaccine Biologics Enteres into Licensing Agreement with National Health Research Institutes 12
Adimmune Enters into Licensing Agreement with National Health Research 13
Microbio Enters into Licensing Agreement with National Health Research Institutes 14
Asset Transactions 15
Genovate Biotech Acquires China Rights to DBPR108 from National Health Research Institutes 15
National Health Research Institutes – Key Employees 16
National Health Research Institutes – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
12/21/2017: Sundia Congratulates NHRI for DBPR114 IND Approval in US & Taiwan 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
National Health Research Institutes, Pharmaceuticals & Healthcare, Key Facts 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Health Research Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Health Research Institutes, Deals By Therapy Area, 2012 to YTD 2018 8
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Targeting Enters into Co-Development Agreement with National Health Research Institutes 10
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
Medigen Vaccine Biologics Enteres into Licensing Agreement with National Health Research Institutes 12
Adimmune Enters into Licensing Agreement with National Health Research 13
Microbio Enters into Licensing Agreement with National Health Research Institutes 14
Genovate Biotech Acquires China Rights to DBPR108 from National Health Research Institutes 15
National Health Research Institutes, Key Employees 16
National Health Research Institutes, Other Locations 17

List of Figures
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Health Research Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[National Health Research Institutes:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inivata Ltd:企業の製品パイプライン分析2018
    Summary Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in …
  • NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Sappi Limited:企業の戦略・SWOT・財務分析
    Sappi Limited - Strategy, SWOT and Corporate Finance Report Summary Sappi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • VA Tech Wabag Ltd (WABAG):企業の財務・戦略的SWOT分析
    Summary VA Tech Wabag Ltd (VA Tech) is engaged in the planning, design, installation and operation of water and wastewater plants. The company’s services include water treatment, desalination, waste water treatment, water reclamation, and sludge treatment. Its projects comprise Sundarijal Water Trea …
  • Archroma Pakistan Ltd. (ARPL):企業の財務・戦略的SWOT分析
    Archroma Pakistan Ltd. (ARPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • RAK Petroleum Plc (RAKP):企業の財務・戦略的SWOT分析
    Summary RAK Petroleum Plc (RAK Petroleum), a subsidiary of RAK Investment Auhtority, is oil and gas company that transports and trades oil, gas and petrochemicals. The company carries out upstream, midstream and downstream activities. It operates its projects in the Middle East and Africa. RAK Petro …
  • Cellmid Ltd (CDY)-製薬・医療分野:企業M&A・提携分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd is a developer of therapies and diagnostic tests. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair …
  • MallInckrodt Plc (MNK):医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt Plc (Mallinckrodt) is develops, produces, commercializes, and distributes specialty pharmaceutical therapies and products. The company offers both branded and specialty generics for autoimmune and rare diseases in the specialty therapeutic areas of rheumatology, nephrology, neur …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Pedernales Electric Cooperative Inc:企業の戦略的SWOT分析
    Pedernales Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Motiva Enterprises LLC:企業の戦略的SWOT分析
    Motiva Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • KION GROUP AG:企業の戦略・SWOT・財務情報
    KION GROUP AG - Strategy, SWOT and Corporate Finance Report Summary KION GROUP AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • KBC Group NV:企業の戦略・SWOT・財務情報
    KBC Group NV - Strategy, SWOT and Corporate Finance Report Summary KBC Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Bechtel Corporation:企業の戦略的SWOT分析
    Bechtel Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Sherwin-Williams Co (SHW):企業の財務・戦略的SWOT分析
    Sherwin-Williams Co (SHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Development Bank:企業の戦略・SWOT・財務分析
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nidec Corporation:戦略・SWOT・企業財務分析
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Carmanah Technologies Corporation (CMH):電力:M&Aディール及び事業提携情報
    Summary Carmanah Technologies Corporation (Carmanah Technologies) is a provider of signal and solar-based light emitting diode (LED) solutions for infrastructure. The company designs, develops and distributes solar powered LED lighting, and solar powered systems and equipment. It also designs, devel …
  • FibroGen Inc (FGEN):企業の財務・戦略的SWOT分析
    FibroGen Inc (FGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mediaset S.p.A.:企業の戦略・SWOT・財務分析
    Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediaset S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆